Literature DB >> 29699075

Evaluation of testicular microlithiasis in varicoceles.

Hideyuki Kobayashi1, Koichi Nagao1, Toshiaki Nakai1, Takamasa Kudo1, Atsumi Yoshida1, Hiroshi Hara1, Kazukiyo Miura1, Nobuhisa Ishii1, Yoshikatsu Sawamura2, Myota Miura3.   

Abstract

Background:  Testicular microlithiasis is said to be characterized by calcific concretions within the seminiferous tubules. There have been reports suggesting a link between testicular microlithiasis and testicular dysfunction and tumors.
Methods:  In this study, we assessed subjects with varicoceles detected by using testicular ultrasound, and evaluated the cases of testicular microlithiasis in terms of age, seminalysis findings, and endocrinological parameters (testosterone, follicular stimulating hormone (FSH), luteinizing hormone (LH), and prolactin (PRL)). The subjects comprised 224 patients with varicoceles diagnosed by using testicular ultrasound, who attended this institution as outpatients between January 1998 and August 2000.
Results:Testicular microlithiasis was detected in 15 out of 224 subjects (6.7%), bilateral in all cases. No significant differences were seen between the group with testicular microlithiasis and the group without testicular microlithiasis, in terms of age, seminalysis findings, and/or endocrinological parameters (testosterone, FSH, LH, prolactin). The incidence of testicular microlithiasis in outpatients undergoing testicular ultrasound varies between reports, but is of the order of 0.6-2.0%.
Conclusion:  In this study, we found a high proportion of testicular microlithiasis at 6.7%, strongly suggesting a link with male infertility. (Reprod Med Biol 2002; 1: 75-79).

Entities:  

Keywords:  male infertility; testicular microlithiasis; varicocele

Year:  2002        PMID: 29699075      PMCID: PMC5906889          DOI: 10.1046/j.1445-5781.2002.00013.x

Source DB:  PubMed          Journal:  Reprod Med Biol        ISSN: 1445-5781


  14 in total

1.  Testicular microlithiasis: prevalence and tumor risk in a population referred for scrotal sonography.

Authors:  J E Cast; W M Nelson; A S Early; S Biyani; G Cooksey; N G Warnock; D J Breen
Journal:  AJR Am J Roentgenol       Date:  2000-12       Impact factor: 3.959

2.  [Clinicopathological study of the testicular microlithiasis].

Authors:  Y Maeda; K Komatsu; Y Iwasa; J Kanaya; E Koh; M Namiki; S Miwa; H Fuse; S Hirano; N Kondoh; M Koga; M Takeyama; K Matsumiya
Journal:  Nihon Hinyokika Gakkai Zasshi       Date:  2000 Oct-Nov

3.  Testicular microlithiasis: US follow-up.

Authors:  H F Bennett; W D Middleton; A D Bullock; S A Teefey
Journal:  Radiology       Date:  2001-02       Impact factor: 11.105

4.  Testicular microlithiasis: association with male infertility.

Authors:  R I Aizenstein; D DiDomenico; A C Wilbur; H K O'Neil
Journal:  J Clin Ultrasound       Date:  1998-05       Impact factor: 0.910

5.  Is routine scrotal ultrasound advantageous in infertile men?

Authors:  F H Pierik; G R Dohle; J M van Muiswinkel; J T Vreeburg; R F Weber
Journal:  J Urol       Date:  1999-11       Impact factor: 7.450

Review 6.  Testicular microlithiasis is associated with testicular pathology.

Authors:  J P Ganem; K R Workman; S F Shaban
Journal:  Urology       Date:  1999-01       Impact factor: 2.649

7.  Testicular microlithiasis: imaging appearances and pathologic correlation.

Authors:  M L Backus; L A Mack; W D Middleton; B F King; T C Winter; L D True
Journal:  Radiology       Date:  1994-09       Impact factor: 11.105

8.  Incidence and implication of testicular microlithiasis detected by scrotal duplex sonography in a select group of infertile men.

Authors:  D N Kessaris; B C Mellinger
Journal:  J Urol       Date:  1994-11       Impact factor: 7.450

9.  Testicular calcifications: incidence, histology and proposed pathological criteria for testicular microlithiasis.

Authors:  A A Renshaw
Journal:  J Urol       Date:  1998-11       Impact factor: 7.450

10.  Incidence of testicular microlithiasis.

Authors:  K Höbarth; M Susani; N Szabo; C Kratzik
Journal:  Urology       Date:  1992-11       Impact factor: 2.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.